Notizie Synaptogenix - SNPX

Ultime notizie

Data	Ora	Fonte	Titolo
20/12/2024	15:21	EDGAR2	Form 8-K - Current report
20/12/2024	15:15	PRNUS	Synaptogenix Board of Directors Forms Special Committee to..
06/12/2024	23:06	EDGAR2	Form 8-K - Current report
12/11/2024	23:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/2024	14:54	EDGAR2	Form DEF 14A - Other definitive proxy statements
05/11/2024	12:01	EDGAR2	Form ARS - Annual Report to Security Holders
28/10/2024	21:00	EDGAR2	Form PRE 14A - Other preliminary proxy statements
10/10/2024	23:11	EDGAR2	Form S-3 - Registration statement under Securities Act of..
04/10/2024	22:30	EDGAR2	Form 8-K - Current report
13/9/2024	22:54	EDGAR2	Form 8-K - Current report
11/9/2024	15:00	EDGAR2	Form 8-K - Current report
11/9/2024	15:00	PRNUS	Synaptogenix Announces $5.0 Million Financing
09/9/2024	23:00	EDGAR2	Form 8-K - Current report
14/8/2024	22:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
18/7/2024	15:00	PRNUS	Synaptogenix Announces New Collaboration with LSU Health New..
26/6/2024	15:00	PRNUS	Synaptogenix Announces FDA Authorization of IND Application..
15/5/2024	23:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/2024	15:00	PRNUS	Synaptogenix Applauds DEA Proposal to Reclassify Cannabis..
24/4/2024	15:15	PRNUS	Synaptogenix Regains Compliance with Nasdaq Minimum Bid..
09/4/2024	15:15	PRNUS	Synaptogenix Increases Stake in Innovative Psilocybin Drug..
03/4/2024	14:00	PRNUS	Synaptogenix Announces Reverse Stock Split to Maintain..
06/2/2024	16:16	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..

Apertura: 3,49	Min: 3,3248	Max: 3,74
Chiusura: 3,54